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Abstract
The dynamic nature of gene expression enables cellular programming, homeostasis, and 
environmental adaptation in living systems. Dissection of causal gene functions in cellular and 
organismal processes therefore necessitates approaches that enable spatially and temporally 
precise modulation of gene expression. Recently, a variety of microbial and plant-derived light-
sensitive proteins have been engineered as optogenetic actuators, enabling high precision 
spatiotemporal control of many cellular functions1-11. However, versatile and robust technologies 
that enable optical modulation of transcription in the mammalian endogenous genome remain 
elusive. Here, we describe the development of Light-Inducible Transcriptional Effectors (LITEs), 
an optogenetic two-hybrid system integrating the customizable TALE DNA-binding domain12-14 
with the light-sensitive cryptochrome 2 protein and its interacting partner CIB1 from Arabidopsis 
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thaliana. LITEs do not require additional exogenous chemical co-factors, are easily customized to 
target many endogenous genomic loci, and can be activated within minutes with 
reversibility3,4,6,7,15. LITEs can be packaged into viral vectors and genetically targeted to probe 
specific cell populations. We have applied this system in primary mouse neurons, as well as in the 
brain of awake mice in vivo to mediate reversible modulation of mammalian endogenous gene 
expression as well as targeted epigenetic chromatin modifications. The LITE system establishes a 
novel mode of optogenetic control of endogenous cellular processes and enables direct testing of 
the causal roles of genetic and epigenetic regulation in normal biological processes and disease 
states.
The LITE system employs a modular design consisting of two independent components 
(Fig. 1a): The first component is the genomic anchor and includes a customizable DNA-
binding domain, based on transcription activator-like effectors (TALEs)12,13 from 
Xanthamonas sp., fused to the light-sensitive cryptochrome 2 (CRY2) protein from 
Arabidopsis thaliana6,15 (TALE-CRY2). The second component includes CRY2’s 
interacting partner CIB16,15 fused to a desired effector domain (CIB1-effector). In the 
absence of light (inactive state), TALE-CRY2 binds the promoter region of the target gene 
while CIB1-effector remains free within the nuclear compartment. Illumination with blue 
light (peak ~450 nm) triggers a conformational change in CRY2 and subsequently recruits 
CIB1-effector (VP64 shown in Fig. 1a) to the target locus to mediate transcriptional 
modulation. This modular design allows each LITE component to be independently 
engineered, allowing the same genomic anchor to be combined with activating or repressing 
effectors16,17 to exert positive and negative transcriptional control over the same 
endogenous genomic locus. In principle, the genomic anchor may also be replaced with 
other DNA binding domains such as zinc finger proteins16 or RNA-guided DNA binding 
domains based on nucleolytically inactive mutants of Cas9 (Extended Data Fig. 1)18-22.
In order to identify the most effective architecture, we assessed the efficacy of different 
LITE designs by measuring blue light illumination induced transcriptional changes of the 
neural lineage-specifying transcription factor neurogenin 2 (Neurog2) (Fig. 1b). 3 out of 4 
initial LITE pairings produced significant light-induced Neurog2 mRNA up-regulation in 
Neuro 2a cells (p < 0.001, Fig. 1b). Of these, TALE(Neurog2)-CRY2PHR::CIB1-VP64 
yielded strongest light-mediated transcription activation as well as the highest induction 
ratio (light/no light mRNA levels). Therefore TALE-CRY2PHR::CIB1-VP64 was used in 
subsequent experiments. To ensure optimal function, we also systematically tuned light 
stimulation parameters (wavelength, Extended Data Fig. 2a; duty cycle, Extended Data Fig. 
2b; light intensity, Extended Data Fig. 2c and d, and Supplementary Discussion23; and 
choice of activation domain, Extended Data Fig. 2e).
Although the interaction between CRY2 and CIB1 occurs on a sub-second timescale6, 
LITE-mediated transcriptional activation is likely dependent on many factors, including rate 
of transcription, mRNA processing, and transcript stability24,25. We found that LITE-
mediated Neurog2 expression increased considerably as early as 30 min after initial 
stimulation and rose steadily until saturating at 12 h with approximately 20-fold up-
regulation compared to GFP-transfected negative controls (Fig. 1c). Interestingly, Neurog2 
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transcript levels continued to increase for up to 30 min post-illumination, an effect that may 
have resulted from residual CRY2PHR-CIB1 dimerization or from previously recruited 
RNA polymerases. Thereafter, Neurog2 mRNA returned to baseline levels with a half-life of 
~3 h. In contrast, a small-molecule inducible TALE system based on the plant hormone 
abcisic acid receptor26 exhibited slower on- and off-kinetics (Extended Data Fig. 3).
To apply LITE for neuronal applications, we developed an adeno-associated virus (AAV)-
based vector (Figs. 2a, b) for the delivery of TALE genes and a simplified process for AAV 
production (Extended Data Fig. 4 and Online Methods). The ssDNA-based genome of 
AAV is less susceptible to recombination, providing an advantage over lentiviral vectors27. 
We evaluated a panel of 28 TALE activators targeting the mouse genome in primary 
neurons and found that most were able to up-regulate transcription in primary neurons (Fig. 
2c). Moreover, in vivo expression of TALE(Grm2)-VP64 in the prefrontal cortex (PFC) 
(Fig. 2d and e) induced a 2.5-fold increase in Grm2 mRNA levels compared to GFP-only 
controls (Fig. 2f).
Similarly, we introduced LITEs into primary cortical neurons via co-delivery of two AAVs 
(Fig. 3a, b). We tested a Grm2-targeted LITE at 2 light pulsing frequencies with a reduced 
duty cycle of 0.8% to ensure neuron health (Extended Data Fig. 5a). Both stimulation 
conditions achieved a ~7-fold light-dependent increase in Grm2 mRNA levels (Fig. 3c). 
Further study verified that substantial target gene expression increases could be attained 
quickly (4-fold up-regulation of mRNA within 4 h; Fig. 3d). In addition, we observed 
significant up-regulation of mGluR2 protein after stimulation, confirming that LITE-
mediated transcriptional changes are translated to the protein level (p < 0.01 vs GFP control, 
p < 0.05 vs no-light condition; Fig. 3e). To test the in vivo functionality of the LITE system, 
we stereotactically delivered a 1:1 mixture of high titer AAV vectors carrying 
TALE(Grm2)-CIB1 and CRY2PHR-VP64 into the PFC. We used a previously established 
fiber optic cannula system to deliver light to LITE-expressing neurons in vivo (Fig. 3f, g, 
and Extended Data Fig. 5b)28. After 12 h of stimulation, we observed a significant increase 
in Grm2 mRNA compared with unstimulated PFC (Fig. 3h, p ≤ 0.01). Taken together, these 
results confirm that LITEs enable optical control of endogenous gene expression in cultured 
neurons and in vivo.
Given persistent baseline up-regulation in vivo, we undertook further rounds of optimization 
to reduce background activity and improve the gene induction ratio. We observed that 
TALE(Grm2)-CIB1 alone produced similar levels of up-regulation as background 
activation, yet CRY2PHR-VP64 alone did not significantly affect transcription (Extended 
Data Fig. 5c). Therefore we rationalized that LITE-dependent background transcriptional 
activation arises mainly from TALE-CIB1.
The subsequent comprehensive screen to reduce baseline TALE-CIB1-mediated up-
regulation focuses on two strategies: First, although CIB1 is a plant transcription factor, it 
may have intrinsic activity in mammalian cells29. To address this, we deleted three CIB1 
regions conserved amongst basic helix-loop-helix transcription factors of higher plants 
(Extended Data Fig. 6). Second, to prevent TALE-CIB1 from binding the target locus in 
absence of light, we engineered TALE-CIB1 to localize in the cytoplasm pending light-
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induced dimerization with the NLS-containing CRY2PHR-VP64 (Extended Data Fig. 7a 
and b). To test both strategies independently or in combination, we evaluated 73 distinct 
LITE architectures and identified 12 effector-targeting domain pairs (denoted by the “+” 
column in Extended Data Fig. 6) with both improved light-induction efficiency and reduced 
background (fold mRNA increase in the no-light condition compared with the original 
LITE; p < 0.05). One architecture successfully incorporating both strategies, designated 
LITE2.0, demonstrated the strongest light induction (light/no-light = 20.4) and resulted in 
greater than 6-fold reduction of background activation compared with the original design 
(Fig. 3i). Another – LITE1.9.1 – produced minimal background activation (1.06) while 
maintaining four-fold light induction (Extended Data Fig. 7c).
Finally, we sought to expand the range of transcriptional processes modulatable by TALE 
and LITE. We hypothesized that TALE-mediated targeting of histone effectors to 
endogenous loci could induce specific epigenetic modifications, which would enable the 
interrogation of epigenetic as well as transcriptional dynamics (Fig. 4a). We fused 
CRY2PHR with SID4X (Fig. 4b and Extended Data Fig. 8) and observed light-mediated 
transcription repression of Grm2 in neurons (Fig. 4c, d) accompanied by ~2-fold reduction 
in H3K9 acetylation at the targeted Grm2 promoter (Fig. 4d). In order to expand the 
diversity of histone residue targets for locus-specific histone modification, we next derived a 
set of 32 repressive histone effector domains (Supplementary Tables 1-5). Selected from 
across a wide phylogenetic spectrum, the domains include histone deacetylases (HDACs), 
methyltransferases (HMTs), acetyltransferase (HAT) inhibitors, as well as HDAC and HMT 
recruiting proteins. Preference was given to proteins and functional truncations of small size 
to facilitate efficient AAV packaging. The resulting epigenetic mark-modifying TALE-
histone effector fusion constructs (epiTALEs) were evaluated in primary neurons and Neuro 
2a cells for their ability to repress Grm2 and Neurog2 transcription, respectively (Fig. 4e, f 
and Extended Data Fig. 9). In primary neurons, 23 out of 24 epiTALEs successfully 
repressed transcription of Grm2 (p < 0.05). Similarly, epiTALE expression in Neuro 2a cells 
led to decreased Neurog2 expression for 20 of the 32 histone effector domains tested 
(Extended Data Fig. 9; p < 0.05). We then expressed a subset of promising epiTALEs in 
primary neurons and Neuro 2a cells and quantified the relative histone residue mark levels at 
the target locus using ChIP-RT-qPCR (Fig. 4g, h and Extended Data Fig. 10). In primary 
neurons and Neuro 2a cells, levels of H3K9me1, H4K20me3, H3K27me3, H3K9ac, and 
H4K8ac were altered by epiTALEs consisting of, respectively, KYP (A. thaliana), TgSET8 
(T. gondii), NUE and PHF19 (C. trachomatis and H. sapiens), Sin3a, Sirt3 and NcoR, (all 
H. sapiens) and HDAC8, RPD3, and Sir2a (X laevis, S cerevisiae, P falciparum). These 
domains provide a ready source of epigenetic effectors for LITE-mediated control of 
specific epigenetic modifications.
Spatiotemporally precise perturbation of transcription and epigenetic states in vivo using 
LITE enables researchers to test the causal role of gene regulation in diverse processes 
including development, learning, and disease. TALEs can be conveniently customized to 
target a wide range of genomic loci, and other DNA binding domains such as the RNA-
guided Cas9 enzymes may be used in lieu of TALE to enable multiplexed transcriptional 
and epigenetic engineering of individual or groups of genomic loci in cells and whole 
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organisms18-20. Novel modes of LITE modulation can also be achieved by replacing the 
effector module with functional domains such as chromatin modifying enzymes30. The 
LITE system enables a powerful set of novel capabilities for the optogenetic toolbox and 
establishes a highly generalizable and versatile platform for reverse-engineering the 
functional organization of mammalian genomes.
Methods
Design and construction of LITEs
All LITE constructs sequences can be found in Supplementary Sequences. We evaluated 
full-length CRY2 as well as a truncation consisting of the photolyase homology region alone 
(CRY2PHR, amino acids 1-498)6. For CIB1, we tested the full-length protein as well as an 
N-terminal domain-only fragment (CIBN, amino acids 1-170)6. The efficacy of each design 
is determined based on the level of light-dependent up-regulation of the endogenous target 
Neurog2 mRNA (Fig. 1b). In order to use AAV as a vector for the delivery of LITE 
components, we needed to ensure that the total viral genome size of each recombinant AAV, 
with the LITE transgenes included, did not exceed the packaging limit of 4.8 kb31. We 
shortened the TALE N- and C-termini (keeping 136 aa in the N-terminus and 63 aa in the C-
terminus) and exchanged the CRY2PHR (1.5kb) and CIB1 (1kb) domains (TALE-CIB1 and 
CRY2PHR-VP64; Fig. 3a). TALE binding sequences were selected based on DNase I-
sensitive regions in the promoter of each target gene. TALE targeting sequence are listed in 
Supplementary Table 6.
Neuro 2a culture and experiments
Neuro 2a cells (Sigma-Aldrich) were grown in media containing a 1:1 ratio of OptiMEM 
(Life Technologies) to high-glucose DMEM with GlutaMax and Sodium Pyruvate (Life 
Technologies) supplemented with 5% HyClone heat-inactivated FBS (Thermo Scientific), 
1% penicillin/streptomycin (Life Technologies), and passaged at 1:5 every 2 days. 120,000 
cells were plated in each well of a 24-well plate 18-20 h prior to transfection. 1 h before 
transfection, media was changed to DMEM supplemented with 5% HyClone heat-
inactivated FBS and 1% penicillin/streptomycin. Cells were transfected with 1.0 μg total of 
construct DNA (at equimolar ratios) per well with 1.5 μL of GenJet (SignaGen Laboratories) 
transfection reagent according to the manufacturer’s instructions. Media was exchanged 24 
h and 44 h post-transfection and light stimulation was started at 48 h. Stimulation parameters 
were: 5 mW/cm2, 466 nm, 7 % duty cycle (1 s light pulse 0.067 Hz) for 24 h unless 
indicated otherwise in figure legends. RNA was extracted using the RNeasy kit (Qiagen) 
according to manufacturer’s instructions and 1 μg of RNA per sample was reverse-
transcribed using qScript (Quanta Biosystems). Relative mRNA levels were measured by 
quantitative real-time PCR (qRT-PCR) using TaqMan probes specific for the targeted gene 
as well as GAPDH as an endogenous control (Life Technologies, see Supplementary Table 
7 for Taqman probe IDs). ΔΔCt analysis was used to obtain fold-changes relative to negative 
controls transduced with GFP only and subjected to light stimulation. Toxicity experiments 
were conducted using the LIVE/DEAD assay kit (Life Technologies) according to 
manufacturer’s protocol.
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AAV vector production
The ssDNA-based genome of AAV is less susceptible to recombination, thus providing an 
advantage over RNA-based lentiviral vectors27 for the packaging and delivery of highly 
repetitive TALE sequences. 293FT cells (Life Technologies) were grown in antibiotic-free 
D10 media (DMEM high glucose with GlutaMax and Sodium Pyruvate, 10% heat-
inactivated Hyclone FBS, and 1% 1M HEPES) and passaged daily at 1:2-2.5. The total 
number of passages was kept below 10 and cells were never grown beyond 85% confluence. 
The day before transfection, 1×106 cells in 21.5 mL of D10 media were plated onto 15 cm 
dishes and incubated for 18-22 hours or until ~80% confluence. For use as a transfection 
reagent, 1 mg/mL of PEI “Max” (Polysciences) was dissolved in water and the pH of the 
solution was adjusted to 7.1. For AAV production, 10.4 μg of pDF6 helper plasmid, 8.7 μg 
of pAAV1 serotype packaging vector, and 5.2 μg of pAAV vector carrying the gene of 
interest were added to 434 μL of serum-free DMEM and 130 μL of PEI “Max” solution was 
added to the DMEM-diluted DNA mixture. The DNA/DMEM/PEI cocktail was vortexed 
and incubated at room temperature for 15 min. After incubation, the transfection mixture 
was added to 22 mL of complete media, vortexed briefly, and used to replace the media for a 
15 cm dish of 293FT cells. For supernatant production, transfection supernatant was 
harvested at 48 h, filtered through a 0.45 μm PVDF filter (Millipore), distributed into 
aliquots, and frozen for storage at −80°C.
Primary cortical neuron culture
Dissociated cortical neurons were prepared from C57BL/6N mouse embryos on E16 
(Charles River Labs). Cortical tissue was dissected in ice-cold HBSS – (50 mL 10× HBSS, 
435 mL dH2O, 0.3 M HEPES pH 7.3, and 1% penicillin/streptomycin). Cortical tissue was 
washed 3× with 20 mL of ice-cold HBSS and then digested at 37°C for 20 min in 8 mL of 
HBSS with 240 μL of 2.5% trypsin (Life Technologies). Cortices were then washed 3 times 
with 20 mL of warm HBSS containing 1 mL FBS. Cortices were gently triturated in 2 ml of 
HBSS and plated at 150,000 cells/well in poly-D-lysine coated 24-well plates (BD 
Biosciences). Neurons were maintained in Neurobasal media (Life Technologies), 
supplemented with 1× B27 (Life Technologies), GlutaMax (Life Technologies) and 1% 
penicillin/streptomycin.
Primary neuron transduction and light stimulation experiments
Primary cortical neurons were transduced with 250 μL of AAV1 supernatant on DIV 5. The 
media and supernatant were replaced with regular complete neurobasal the following day. 
Neurobasal was exchanged with Minimal Essential Medium (Life Technologies) containing 
1× B27, GlutaMax (Life Technologies) and 1% penicillin/streptomycin 6 days after AAV 
transduction to prevent formation of phototoxic products from HEPES and riboflavin 
contained in Neurobasal during light stimulation. For co-transduction of primary neurons 
with two AAV vectors, the co-delivery efficiency is >80%, with individual components 
having transduction efficiencies between 83-92%.
Light stimulation was started 6 days after AAV transduction (DIV 11) with an intensity of 5 
mW/cm2, duty cycle of 0.8% (250 ms pulses at 0.033Hz or 500 ms pulses at 0.016Hz), 466 
nm blue light for 24 h unless indicated otherwise in figure legends. RNA extraction and 
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reverse transcription were performed using the Cells-to-Ct kit according to the 
manufacturers instructions (Life Technologies). Relative mRNA levels were measured by 
quantitative real-time PCR (qRT-PCR) using TaqMan probes as described above for Neuro 
2a cells.
Immunohistochemistry of primary neurons
For immunohistochemistry of primary neurons, cells were plated on poly-D-lysine/laminin 
coated coverslips (BD Biosciences) after harvesting. AAV1-transductions were performed 
as described above. Neurons were fixed 7 days post-transduction with 4% paraformaldehyde 
(Sigma Aldrich) for 15 min at RT. Blocking and permeabilization were performed with 10% 
normal goat serum (Life Technologies) and 0.5% Triton-X100 (Sigma-Aldrich) in DPBS 
(Life Technologies) for 1 h at room temperature. Neurons were incubated with primary 
antibodies overnight at 4°C, washed 3× with DPBS and incubated with secondary antibodies 
for 90 min at RT. For antibody providers and concentrations used, see Supplementary Table 
8. Coverslips were finally mounted using Prolong Gold Antifade Reagent with DAPI (Life 
Technologies) and imaged on an Axio Scope A.1 (Zeiss) with an X-Cite 120Q light source 
(Lumen Dynamics). Image were acquired using an AxioCam MRm camera and AxioVision 
4.8.2.
Western Blots
For preparation of total protein lysates, primary cortical neurons were harvested after light 
stimulation (see above) in ice-cold lysis buffer (RIPA, Cell Signaling; 0.1% SDS, Sigma-
Aldrich; and cOmplete ULTRA protease inhibitor mix, Roche Applied Science). Cell lysates 
were sonicated for 5 min at ‘M’ setting with the Bioruptor water bath sonicator (Diagenode) 
and centrifuged at 21,000 × g for 10 min at 4°C. Protein concentration was determined using 
the RC DC protein assay (Bio-Rad). 30-40 μg of total protein per lane was separated under 
non-reducing conditions on 4-15% Tris-HCl gels (Bio-Rad) along with Precision Plus 
Protein Dual Color Standard (Bio-Rad) After wet electrotransfer to polyvinylidene 
difluoride membranes (Millipore) and membrane blocking for 45 min in 5% BLOT-
QuickBlocker (Millipore) in Tris-buffered saline (TBS, Bio-Rad), western blots were probed 
with anti-mGluR2 (Abcam, 1:1.000) and anti-μ-tubulin (Sigma-Aldrich 1:20,000) overnight 
at 4°C, followed by washing and anti-mouse-IgG HRP antibody incubation (Sigma-Aldrich, 
1:5,000 – 1:10,000). For further antibody details see Supplementary Table 8. Detection was 
performed via ECL Western blot substrate (SuperSignal West Femto Kit, Thermo 
Scientific). Blots were imaged with an AlphaImager system (Innotech), and quantified using 
ImageJ software 1.46r.
Production of concentrated and purified AAV1/2 vectors
Production of concentrated and purified AAV for stereotactic injection in vivo was 
performed using the same initial steps outlined above for production of AAV1 supernatant. 
However, for transfection, equal ratios of AAV1 and AAV2 serotype plasmids were used 
instead of AAV1 alone. Five 15cm plates were transfected per construct and cells were 
harvested with a cell-scraper 48 h post transfection. Purification of AAV1/2 particles was 
performed using HiTrap heparin affinity columns (GE Healthcare)32. We added a second 
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concentration step down to a final volume of 100 μl per construct using an Amicon 500 μl 
concentration column (100 kDa cutoff, Millipore) to achieve higher viral titers. Titration of 
AAV was performed by qRT-PCR using a custom Taqman probe for WPRE (Life 
Technologies). Prior to qRT-PCR, concentrated AAV was treated with DNaseI (New 
England Biolabs) to achieve a measurement of DNaseI-resistant particles only. Following 
DNaseI heat-inactivation, the viral envelope was degraded by Proteinase K digestion (New 
England Biolabs). Viral titer was calculated based on a standard curve with known WPRE 
copy numbers.
Stereotactic injection of AAV1/2 and optical implant
All animal procedures were approved by the MIT Committee on Animal Care. Adult (10-14 
weeks old) male C57BL/6N mice were anaesthetized by intraperitoneal (i.p.) injection of 
Ketamine/Xylazine (100 mg/kg Ketamine and 10 mg/kg Xylazine) and pre-emptive 
analgesia was applied (Buprenex, 1 mg/kg, i.p.). Craniotomy was performed according to 
approved procedures and 1μl of AAV1/2 was injected into ILC at 0.35/1.94/-2.94 (lateral, 
anterior and inferior coordinates in mm relative to bregma). During the same surgical 
procedure, an optical cannula with fiber (Doric Lenses) was implanted into ILC unilaterally 
with the end of the optical fiber located at 0.35/1.94/-2.64 relative to bregma. The cannula 
was affixed to the skull using Metabond dental cement (Parkell Inc) and Jet denture repair 
(Lang Dental) to build a stable, supporting cone. The incision was sutured and proper post-
operative analgesics were administered for three days following surgery.
Immunohistochemistry on ILC brain sections
Mice were injected with a lethal dose of Ketamine/Xylazine anaesthetic and transcardially 
perfused with PBS and 4% paraformaldehyde (PFA). Brains were additionally fixed in 4% 
PFA at 4°C overnight and then transferred to 30% sucrose for cryoprotection overnight at 
room temperature. Brains were then transferred into Tissue-Tek Optimal Cutting 
Temperature (OCT) Compound (Sakura Finetek) and frozen at −80°C. 18 μm sections were 
cut on a cryostat (Leica Biosystems) and mounted on Superfrost Plus glass slides (Thermo 
Fischer). Sections were post-fixed with 4% PFA for 15 min, and immunohistochemistry was 
performed as described for primary neurons above.
Light stimulation and mRNA level analysis in ILC
Neurons at the injection site were efficiently co-transduced by both viruses, with >80% of 
transduced cells expressing both TALE(Grm2)-CIB1 and CRY2PHR-VP64 (Fig. 3g and 
Extended Data Fig. 5b). 8 days post-surgery, awake and freely moving mice were stimulated 
using a 473 nm laser source (OEM Laser Systems) connected to the optical implant via fiber 
patch cables and a rotary joint. Stimulation parameters were the same as used on primary 
neurons: 5 mW (total output), 0.8% duty cycle (500 ms light pulses at 0.016 Hz) for a total 
of 12 h. Brain tissue from the fiber optic cannula implantation site was analyzed (Fig. 3h) 
for changes in Grm2 mRNA. Experimental conditions, including transduced constructs and 
light stimulation are listed in Supplementary Table 9.
After the end of light stimulations, mice were euthanized using CO2 and the prefrontal 
cortices (PFC) were quickly dissected on ice and incubated in RNA later (Qiagen) at 4°C 
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overnight. 200 μm sections were cut in RNA later at 4°C on a vibratome (Leica 
Biosystems). Sections were then frozen on a glass coverslide on dry ice and virally 
transduced ILC was identified under a fluorescent stereomicroscope (Leica M165 FC). A 
0.35 mm diameter punch of ILC, located directly ventrally to the termination of the optical 
fiber tract, was extracted (Harris uni-core, Ted Pella). The brain punch sample was then 
homogenized using an RNase-free pellet-pestle grinder (Kimble Chase) in 50 μl Cells-to-Ct 
RNA lysis buffer and RNA extraction, reverse transcription and qRT-PCR was performed as 
described for primary neuron samples.
Chromatin Immunoprecipitation
Neurons or Neuro 2a cells were cultured and transduced or transfected as described above. 
ChIP samples were prepared as previously described33 with minor adjustments for the cell 
number and cell type. Cells were harvested in 24-well format, washed in 96-well format, and 
transferred to microcentrifuge tubes for lysis. Sample cells were directly lysed by water bath 
sonication with the Biorupter sonication device for 21 minutes using 30s on/off cycles 
(Diagenode). qPCR was used to assess enrichment of histone marks at the targeted locus. 
qPCR primer sequences are listed in Supplementary Table 10.
Statistical analysis
All experiments were performed with a minimum of two independent biological replicates. 
Statistical analysis was performed with Prism (GraphPad) using Student’s two-tailed t-test 
when comparing two conditions, ANOVA with Tukey’s post-hoc analysis when comparing 
multiple samples with each other, and ANOVA with Dunnett’s post-hoc analysis when 
comparing multiple samples to the negative control.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Design and Optimization of the LITE system
(a) Schematic of the LITE system. Light stimulation induces dimerization of CRY2 and 
CIB1, recruiting the effector to the target promoter. (b) LITE architecture was optimized by 
fusing TALE and the transcriptional activator VP6414,16 to different truncations of CRY2 
and CIB16 (n next to each bar). (c) Time course of light-dependent Neurog2 up-regulation 
and decay post-illumination (n = 3 biological replicas; *, p < 0.05; ***, p < 0.001). Cells 
were stimulated with 5 mW/cm2 light (460nm, 1 s pulses at 0.066 Hz). Mean ± s.e.m in all 
panels.
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Figure 2. In vitro and in vivo AAV-mediated TALE delivery targeting endogenous loci in neurons
(a) Schematic AAV vectors for TALE delivery. (b) Representative images of primary 
cortical neurons expressing TALE-VP64. (c) TALE-VP64 constructs targeting a variety of 
endogenous neuronal genes were screened for transcriptional activation in primary cortical 
neurons (*, p < 0.05; **, p < 0.01; ***, p < 0.001; n = 3 biological replicas). (d) TALE-
VP64 expression in PFC. (e) Higher magnification image of TALE-VP64-expressing 
neurons in PFC. (f) Grm2 mRNA up-regulation by TALE-VP64 in vivo in PFC (n = 4 
animals). Mean ± s.e.m in all panels.
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Figure 3. LITE-mediated optogenetic modulation of endogenous transcription in primary 
neurons and in vivo
(a) Schematic of AAV-LITE constructs. (b) Images of primary neurons expressing LITE 
constructs. (c) Light-induced activation of Grm2 in primary neurons after 24 h of 
stimulation (250 ms pulses at 0.033Hz or 500 ms pulses at 0.016Hz; 5mW/cm2; n = 4 
biological replicas). (d) Up-regulation of Grm2 in primary cortical neurons after 4 h or 24 h 
of stimulation. Expression levels are shown relative to neurons transduced with GFP only 
(number of biological replica denoted within graph bars). (e) Light-mediated changes in 
mGluR2 protein levels (n = 7 biological replica). (f) Schematic of in vivo optogenetic 
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stimulation setup. (g) Representative images of PFC neurons expressing both LITE 
components. (h) Light-induced activation of endogenous Grm2 expression using LITEs 
transduced into ILC. (**, p < 0.05; number of animals denoted within graph bars) (i) 
LITE2.0 significantly reduces the level of background activation in Neuro 2a cells (n = 3 
biological replica). Mean ± s.e.m in all panels.
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Figure 4. TALE- and LITE-mediated epigenetic modifications
(a) LITE epigenetic modifiers (epiLITE). (b) epiLITE AAV vectors. (c) epiLITE-mediated 
repression of endogenous Grm2 in neurons (n = 4 biological replicas). (d) epiLITE-mediated 
decrease in H3K9 histone acetylation at the Grm2 promoter (n = 4 biological replicas). (e, f) 
epiTALE-methyltransferases mediated decrease in Grm2 mRNA and corresponding 
enrichment of H3K9me1, H4K20me3, and H3K27me3 at the Grm2 promoter (n denoted 
within graph). (g, h) epiTALE histone deacetylases mediated repression of Grm2 and 
corresponding decreases in H4K8Ac and H3K9Ac marks at the Grm2 promoter (n denoted 
within graph). Mean ± s.e.m in all panels.
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